PENTAMIDINE isetionate, 300mg, powder, vial
STD
DINJPENT3V-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
12/04/2024, 17:47:19
Former
Code(s):
DINJMISC194 DINJZFR0194
6.5.4 - Antipneumocystosis and antitoxoplasmosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.5.5.1 - African trypanosomiasis
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01CX01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
PENTAMIDINE
Therapeutic Action
Antiprotozoal active against Pneumocystis jiroveci (carinii), antitrypanosomal
Indications
Second-line treatment of pneumocystis, in case of intolerance or contraindications to sulfamethoxazole-trimethoprim (cotrimoxazole).
Early phase of Human African Trypanosomiasis
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Reconstitute the powder vial with 10 ml of water for injection.
The reconstituted solution must be given as deep IM injection or IV infusion in 250 ml of 5% glucose.
1 mg pentamidine isétionate is equivalent to 0.57 mg pentamidine base.
300 mg pentamidine isetionate (1 vial) is equivalent to 172.4 mg pentamidine base.
Pentamidine is preferred to suramin (risk of major side effects in filariasis endemic areas).
Storage
- Below 25°C - Protect from sunlight
- After reconstitution, keep the solution refrigerated between 2°C and 8°C for a maximum of 24 hrs.